Perianal Warts

• CLINICAL_TRIALS trial_result · 2023-04-05
  Clinical Trial Update: Topical NVN1000 for the Treatment of External Genital and Perianal Warts [Phase 2]

  Phase 2 trial of topical NVN1000 for external genital and perianal warts completed with results posted.

• FDA approval · 2018-12-19
  FDA Approved: VEREGEN — Supplemental Application (ANI Pharmaceuticals, Inc.)

  FDA approves a supplemental application for Veregen (sinecatechins) from ANI Pharmaceuticals, Inc. This action represents a supplemental app…

• FDA approval · 2013-05-09
  FDA Approved: VEREGEN — Supplemental Application (ANI Pharmaceuticals, Inc.)

  FDA approved a supplemental application for Veregen (sinecatechins) submitted by ANI Pharmaceuticals, Inc. The action relates to the already…

• CLINICAL_TRIALS trial_result · 2010-09-08
  Clinical Trial Update: Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage [Phase 4]

  Phase IV pharmacokinetic study comparing topically applied Veregen 15% with oral green tea intake to assess systemic exposure.

• FDA approval · 2008-02-13
  FDA Approved: VEREGEN — Supplemental Application (ANI Pharmaceuticals, Inc.)

  FDA approved a supplemental application for Veregen (sinecatechins) submitted by ANI Pharmaceuticals, Inc. The supplemental action relates t…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.